Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$0.43 - $0.69 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023

BUY
$0.41 - $0.76 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023

BUY
$0.36 - $0.68 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$0.62 - $0.96 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
$0.72 - $1.31 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022

BUY
$0.88 - $1.56 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022

BUY
$1.26 - $2.83 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021

BUY
$2.56 - $4.08 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021

BUY
$2.33 - $4.7 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021

BUY
$4.06 - $6.82 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021

BUY
$4.16 - $5.4 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020

BUY
$4.6 - $6.74 $0 - $0
0 New
0 $0

About PAINREFORM LTD.


  • Ticker PRFX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,634,200
  • Market Cap $5.64M
  • Description
  • PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-oper...
More about PRFX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.